Bigul

Board Meeting Intimation for Results

Nath Bio-Genes (India) Ltd has informed BSE that the meeting of the Board of Directors of the Company will be held on July 29, 2016, to take on record unaudited financial results for the quarter ended June 30, 2016.
13-07-2016
Bigul

Form A for March 31, 2016

Nath Bio-Genes (India) Ltd has informed BSE about : 1. Standalone Form A for the period ended March 31, 2016
05-07-2016
Bigul

Fixes Book Closure for AGM

Nath Bio-Genes (India) Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from July 21, 2016 to July 28, 2016 (both days inclusive) for the purpose of Annual General Meeting (AGM) of the Company to be held on July 28, 2016.
31-05-2016
Bigul

Standalone Financial Results for March 31, 2016

Nath Bio-Genes (India) Ltd has informed BSE about : 1. Standalone Financial Results for the period ended March 31, 2016
30-05-2016
Bigul

Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Nath Bio-Genes (India) Ltd has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
18-05-2016
Bigul

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

Nath Bio-Genes (India) Ltd has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE
16-05-2016
Bigul

Shareholding for the Period Ended March 31, 2016

Nath Bio-Genes (India) Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2016. For more details, kindly Click here
22-04-2016
Bigul

Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended March 31, 2016

Nath Bio-Genes (India) Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended March 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
12-04-2016
Bigul

Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011

Nath Bio-Genes (India) Ltd has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE
01-04-2016
Next Page
Close

Let's Open Free Demat Account